Taiwan FDA registration a5a4fc1cdf849dfe44ac1d03c811e3a6
Lidelle pregnancy test reagent
TW: 莉黛兒驗孕試劑
Taiwan·Risk Class 2·Lianshang Biotechnology Co., Ltd. Wugu Factory·Registered May 10, 2006 – May 10, 2011CancelledRegistration details
- Analysis ID
- a5a4fc1cdf849dfe44ac1d03c811e3a6
- Customs Code
- DHY00500204807
Company information
- Manufacturer
- Lianshang Biotechnology Co., Ltd. Wugu Factory
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- PRESIDENT PHARMACEUTICAL CORPORATION
Product details
- Intended Use
- Detection of human placental chorionic gonadal hormone in urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- Domestic
Dates and status
- Registration Date
- May 10, 2006
- Expiry Date
- May 10, 2011
- Cancellation Date
- Nov 01, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Lidelle pregnancy test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a5a4fc1cdf849dfe44ac1d03c811e3a6 and manufactured by Lianshang Biotechnology Co., Ltd. Wugu Factory. The authorized representative in Taiwan is PRESIDENT PHARMACEUTICAL CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices